{
  "schema_version": "2.0",
  "doc_id": "946ecafb651b0489de97bcd250d7e2b2be78548676637e773a16433a4fa37a2d",
  "extracted_at": "2026-02-01T08:41:28.995288+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Compound",
      "name": "Phosphodiesterase 4 inhibitors",
      "attributes": {
        "context": "Phosphodiesterase 4 inhibitors and drugs of abuse"
      },
      "source_chunk_ids": [
        "920d282bfa000356cf0f018ee2fd8827"
      ]
    },
    {
      "id": "ent_002",
      "type": "Compound",
      "name": "drugs of abuse",
      "attributes": {
        "context": "Phosphodiesterase 4 inhibitors and drugs of abuse"
      },
      "source_chunk_ids": [
        "920d282bfa000356cf0f018ee2fd8827"
      ]
    },
    {
      "id": "ent_003",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "up-regulation of the cAMP-signaling pathway"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_004",
      "type": "Indication",
      "name": "drug tolerance",
      "attributes": {
        "context": "aspects of drug tolerance"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_005",
      "type": "Indication",
      "name": "dependence",
      "attributes": {
        "context": "and dependence"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_006",
      "type": "Compound",
      "name": "drugs of abuse",
      "attributes": {
        "context": "exposure to drugs of abuse"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_007",
      "type": "Compound",
      "name": "Phosphodiesterase 4",
      "attributes": {
        "context": "Phosphodiesterase 4 (PDE4) is an enzyme"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_008",
      "type": "PharmEffect",
      "name": "reinforcing effects",
      "attributes": {
        "context": "regulate the reinforcing effects"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ]
    },
    {
      "id": "ent_009",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4 is a cAMP-specific phosphodiesterase"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_010",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "cAMP-specific phosphodiesterase"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_011",
      "type": "PharmEffect",
      "name": "reinforcing effects",
      "attributes": {
        "context": "regulates the reinforcing effects of drugs of abuse"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_012",
      "type": "Indication",
      "name": "drugs of abuse",
      "attributes": {
        "context": "reinforcing effects of drugs of abuse"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_013",
      "type": "Compound",
      "name": "cyclic AMP",
      "attributes": {
        "context": "neuroadaptations in cyclic AMP (cAMP) signaling"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_014",
      "type": "PharmEffect",
      "name": "drug tolerance",
      "attributes": {
        "context": "underlie aspects of drug tolerance and dependence"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_015",
      "type": "PharmEffect",
      "name": "dependence",
      "attributes": {
        "context": "drug tolerance and dependence"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_016",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 inhibitors reduce drug intake"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_017",
      "type": "PharmEffect",
      "name": "reduce drug intake",
      "attributes": {
        "context": "PDE4 inhibitors reduce drug intake"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "drug seeking",
      "attributes": {
        "context": "and/or drug seeking for psychostimulants"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_019",
      "type": "Compound",
      "name": "psychostimulants",
      "attributes": {
        "context": "drug seeking for psychostimulants"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_020",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "psychostimulants, alcohol, and opioids"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_021",
      "type": "Compound",
      "name": "opioids",
      "attributes": {
        "context": "alcohol, and opioids"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_022",
      "type": "Indication",
      "name": "substance use disorder",
      "attributes": {
        "context": "therapeutic target for several classes of substance use disorder"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "anti-addictive behavioral effects",
      "attributes": {
        "context": "anti-addictive behavioral effects of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_024",
      "type": "PharmEffect",
      "name": "increase in intracellular cAMP levels",
      "attributes": {
        "context": "widespread increase in intracellular cAMP levels"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_025",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "CNS) distribution of PDE4 isoforms"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_026",
      "type": "PharmEffect",
      "name": "inhibition of PDE4",
      "attributes": {
        "context": "specific inhibition of PDE4 on behavioral models"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_027",
      "type": "Indication",
      "name": "drug addiction",
      "attributes": {
        "context": "behavioral models of drug addiction"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_028",
      "type": "Compound",
      "name": "non-selective PDE4 inhibitors",
      "attributes": {
        "context": "potential of non-selective PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_029",
      "type": "PharmEffect",
      "name": "reduce addiction liability",
      "attributes": {
        "context": "may reduce addiction liability"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_030",
      "type": "Indication",
      "name": "addiction liability",
      "attributes": {
        "context": "may reduce addiction liability"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_031",
      "type": "PharmEffect",
      "name": "minimize the side effects",
      "attributes": {
        "context": "and minimize the side effects"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ]
    },
    {
      "id": "ent_032",
      "type": "Compound",
      "name": "Phosphodiesterases (PDEs)",
      "attributes": {
        "context": "Phosphodiesterases (PDEs) are a family of enzymes"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_033",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "hydrolyze intracellular cAMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_034",
      "type": "Compound",
      "name": "cGMP",
      "attributes": {
        "context": "hydrolyze intracellular cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_035",
      "type": "Compound",
      "name": "PDE1",
      "attributes": {
        "context": "PDE1, PDE2, PDE3, PDE10, and PDE11 hydrolyze both cAMP and cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_036",
      "type": "Compound",
      "name": "PDE2",
      "attributes": {
        "context": "PDE1, PDE2, PDE3, PDE10, and PDE11 hydrolyze both cAMP and cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "PDE3",
      "attributes": {
        "context": "PDE1, PDE2, PDE3, PDE10, and PDE11 hydrolyze both cAMP and cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4, PDE7, and PDE8 are specific for cAMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_039",
      "type": "Compound",
      "name": "PDE7",
      "attributes": {
        "context": "PDE4, PDE7, and PDE8 are specific for cAMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "PDE8",
      "attributes": {
        "context": "PDE4, PDE7, and PDE8 are specific for cAMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "PDE5",
      "attributes": {
        "context": "PDE5, PDE6, and PDE9 are specific for cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "PDE6",
      "attributes": {
        "context": "PDE5, PDE6, and PDE9 are specific for cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_043",
      "type": "Compound",
      "name": "PDE9",
      "attributes": {
        "context": "PDE5, PDE6, and PDE9 are specific for cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_044",
      "type": "Compound",
      "name": "PDE10",
      "attributes": {
        "context": "PDE1, PDE2, PDE3, PDE10, and PDE11 hydrolyze both cAMP and cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_045",
      "type": "Compound",
      "name": "PDE11",
      "attributes": {
        "context": "PDE1, PDE2, PDE3, PDE10, and PDE11 hydrolyze both cAMP and cGMP"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_046",
      "type": "Indication",
      "name": "substance abuse",
      "attributes": {
        "context": "treatment of substance abuse"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_047",
      "type": "Indication",
      "name": "substance use disorders",
      "attributes": {
        "context": "substance use disorders"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 and PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ]
    },
    {
      "id": "ent_049",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "PDE4 isoforms"
      },
      "source_chunk_ids": [
        "fe183cdf2221319e24cc3d6ab0fc6c69"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "PDE4B mRNA",
      "attributes": {
        "context": "PDE4B mRNA is high in the human and rodent striatum"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_051",
      "type": "Compound",
      "name": "PDE4A mRNA",
      "attributes": {
        "context": "PDE4A and PDE4D mRNA levels are present in lower amounts"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_052",
      "type": "Compound",
      "name": "PDE4D mRNA",
      "attributes": {
        "context": "PDE4A and PDE4D mRNA levels are present in lower amounts"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_053",
      "type": "Compound",
      "name": "PDE4B protein",
      "attributes": {
        "context": "PDE4B-immunopositive neurons and neuropil are observed"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_054",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "PDE4B is differentially expressed in two major, functionally distinct subpopulations"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_055",
      "type": "Compound",
      "name": "dopamine D1 receptor",
      "attributes": {
        "context": "dopamine D1 receptor-expressing \u201cdirect\u201d (striatonigral) output pathway"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_056",
      "type": "Compound",
      "name": "dopamine D2 receptor",
      "attributes": {
        "context": "dopamine D2 receptor-expressing \u201cindirect\u201d (striatopallidal) output pathway"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_057",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine D1 receptor-expressing \u201cdirect\u201d (striatonigral) output pathway"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_058",
      "type": "PharmEffect",
      "name": "behaviorally stimulating",
      "attributes": {
        "context": "the direct pathway is behaviorally stimulating"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "behaviorally suppressant",
      "attributes": {
        "context": "the indirect pathway is behaviorally suppressant"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "PDE4B protein",
      "attributes": {
        "context": "PDE4B protein is also abundant in the ventral pallidum"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "selectively bred alcohol preferring rats"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "PDE4A mRNA",
      "attributes": {
        "context": "PDE4A mRNA was elevated and PDE4B2 mRNA was reduced"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "PDE4B2 mRNA",
      "attributes": {
        "context": "PDE4B2 mRNA was reduced in the accumbens"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ]
    },
    {
      "id": "ent_064",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "measuring PDE4 isoforms"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "PDE4D mRNA",
      "attributes": {
        "context": "PDE4D mRNA was the highest"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "while 4B was lower"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ]
    },
    {
      "id": "ent_067",
      "type": "Compound",
      "name": "PDE4A",
      "attributes": {
        "context": "and 4A was not detected"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "saline",
      "attributes": {
        "context": "after a saline infusion"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "after a cocaine infusion"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "flumazenil",
      "attributes": {
        "context": "pretreatment with flumazenil"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_071",
      "type": "Compound",
      "name": "benzodiazepine",
      "attributes": {
        "context": "antagonist of the benzodiazepine binding site"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_072",
      "type": "Compound",
      "name": "diazepam",
      "attributes": {
        "context": "reduces the percentage of diazepam-appropriate responses"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "treatment with amphetamine"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "Although PDE4 inhibitors are known"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ]
    },
    {
      "id": "ent_075",
      "type": "PharmEffect",
      "name": "enhance cognitive functions",
      "attributes": {
        "context": "known to enhance cognitive functions"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ]
    },
    {
      "id": "ent_076",
      "type": "PharmEffect",
      "name": "learning",
      "attributes": {
        "context": "such as learning and memory"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ]
    },
    {
      "id": "ent_077",
      "type": "PharmEffect",
      "name": "memory",
      "attributes": {
        "context": "learning and memory"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ]
    },
    {
      "id": "ent_078",
      "type": "Indication",
      "name": "cognitive decline",
      "attributes": {
        "context": "pharmacotherapy of cognitive decline"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ]
    },
    {
      "id": "ent_079",
      "type": "Compound",
      "name": "Methamphetamine",
      "attributes": {
        "context": "Methamphetamine: Beardsley and coworkers"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_080",
      "type": "PharmEffect",
      "name": "PDE inhibitor",
      "attributes": {
        "context": "non-selective PDE inhibitor ibudilast"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_081",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "PDE inhibitor ibudilast and its analogs"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_082",
      "type": "Indication",
      "name": "methamphetamine abuse",
      "attributes": {
        "context": "on methamphetamine abuse"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_083",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "effects on cocaine-associated hyperlocomotion"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_084",
      "type": "PharmEffect",
      "name": "hyperlocomotion",
      "attributes": {
        "context": "cocaine-associated hyperlocomotion"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_085",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "ibudilast and its analog AV1013"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_086",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {
        "context": "ibudilast and its analog AV1013"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_087",
      "type": "PharmEffect",
      "name": "reduce the methamphetamine-induced increase in locomotor activity",
      "attributes": {
        "context": "reduce the methamphetamine-induced increase in locomotor activity"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_088",
      "type": "PharmEffect",
      "name": "sensitization",
      "attributes": {
        "context": "locomotor activity and sensitization"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_089",
      "type": "PharmEffect",
      "name": "affecting locomotor activity",
      "attributes": {
        "context": "significantly affecting locomotor activity"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "ibudilast and AV1013 are effective"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_091",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {
        "context": "ibudilast and AV1013 are effective"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_092",
      "type": "PharmEffect",
      "name": "attenuating methamphetamine self-administration",
      "attributes": {
        "context": "attenuating methamphetamine self-administration"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_093",
      "type": "PharmEffect",
      "name": "drug seeking behavior",
      "attributes": {
        "context": "and drug seeking behavior"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_094",
      "type": "PharmEffect",
      "name": "reduces methamphetamine self-administration",
      "attributes": {
        "context": "reduces methamphetamine self-administration on an FR1 schedule"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_095",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "Systemic ibudilast and AV1013"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_096",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {
        "context": "Systemic ibudilast and AV1013"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_097",
      "type": "PharmEffect",
      "name": "reduces footshock- and prime-induced reinstatement of methamphetamine-seeking",
      "attributes": {
        "context": "reduces footshock- and prime-induced reinstatement of methamphetamine-seeking"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_098",
      "type": "PharmEffect",
      "name": "reduction of drug seeking behavior",
      "attributes": {
        "context": "the reduction of drug seeking behavior"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_099",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "by ibudilast and its analog"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_100",
      "type": "PharmEffect",
      "name": "inflammatory processes",
      "attributes": {
        "context": "associated with inflammatory processes"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_101",
      "type": "Compound",
      "name": "Methamphetamine",
      "attributes": {
        "context": "Methamphetamine activates glial cells"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_102",
      "type": "PharmEffect",
      "name": "activates glial cells",
      "attributes": {
        "context": "activates glial cells"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_103",
      "type": "PharmEffect",
      "name": "increases proinflammatory cytokine production",
      "attributes": {
        "context": "increases proinflammatory cytokine production in the brain"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_104",
      "type": "PharmEffect",
      "name": "glial cell activation",
      "attributes": {
        "context": "glial cell activation and inflammatory responses"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_105",
      "type": "PharmEffect",
      "name": "inflammatory responses",
      "attributes": {
        "context": "and inflammatory responses have been linked"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_106",
      "type": "Indication",
      "name": "drug abuse-related behavior",
      "attributes": {
        "context": "linked to drug abuse-related behavior"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_107",
      "type": "Compound",
      "name": "Ibudilast",
      "attributes": {
        "context": "Ibudilast inhibits both PDE"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_108",
      "type": "PharmEffect",
      "name": "inhibits PDE",
      "attributes": {
        "context": "inhibits both PDE and glial proinflammatory activity"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_109",
      "type": "PharmEffect",
      "name": "glial proinflammatory activity",
      "attributes": {
        "context": "and glial proinflammatory activity"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ]
    },
    {
      "id": "ent_110",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {
        "context": "AV1013 shares the anti-inflammatory activity"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_111",
      "type": "PharmEffect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "context": "shares the anti-inflammatory activity"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_112",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "activity of ibudilast"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_113",
      "type": "Compound",
      "name": "PDE",
      "attributes": {
        "context": "negligibly inhibits PDE"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_114",
      "type": "PharmEffect",
      "name": "glial inflammatory activity",
      "attributes": {
        "context": "modulation of glial inflammatory activity"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_115",
      "type": "PharmEffect",
      "name": "attenuation",
      "attributes": {
        "context": "contributes to the attenuation"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_116",
      "type": "PharmEffect",
      "name": "methamphetamine-induced locomotor sensitization",
      "attributes": {
        "context": "attenuation of methamphetamine-induced locomotor sensitization"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_117",
      "type": "PharmEffect",
      "name": "relapse of drug seeking",
      "attributes": {
        "context": "relapse of drug seeking by ibudilast"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_118",
      "type": "Indication",
      "name": "methamphetamine abuse",
      "attributes": {
        "context": "treating methamphetamine abuse"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ]
    },
    {
      "id": "ent_119",
      "type": "Compound",
      "name": "Alcohol",
      "attributes": {
        "context": "Alcohol: Regulation of alcohol drinking"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_120",
      "type": "Compound",
      "name": "PDEs",
      "attributes": {
        "context": "subtypes of PDEs"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_121",
      "type": "PharmEffect",
      "name": "alcohol drinking",
      "attributes": {
        "context": "Regulation of alcohol drinking"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_122",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "behavioral effects of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_123",
      "type": "PharmEffect",
      "name": "behavioral effects",
      "attributes": {
        "context": "studying behavioral effects of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_124",
      "type": "PharmEffect",
      "name": "alcohol drinking",
      "attributes": {
        "context": "inhibitors on alcohol drinking"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ]
    },
    {
      "id": "ent_125",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "Reduction of alcohol drinking by PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_126",
      "type": "Indication",
      "name": "alcohol drinking",
      "attributes": {
        "context": "Reduction of alcohol drinking"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_127",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "access to alcohol"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_128",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {
        "context": "Rolipram and Ro 20-1724"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_129",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {
        "context": "Rolipram and Ro 20-1724"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_130",
      "type": "PharmEffect",
      "name": "reduce alcohol intake and preference",
      "attributes": {
        "context": "Rolipram and Ro 20-1724 reduce alcohol intake and preference"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_131",
      "type": "Compound",
      "name": "sucrose",
      "attributes": {
        "context": "intake of sucrose"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_132",
      "type": "Compound",
      "name": "quinine",
      "attributes": {
        "context": "intake of sucrose or quinine"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_133",
      "type": "PharmEffect",
      "name": "alcohol-induced sedation",
      "attributes": {
        "context": "alcohol-induced sedation"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_134",
      "type": "PharmEffect",
      "name": "alcohol metabolism",
      "attributes": {
        "context": "or alcohol metabolism"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_135",
      "type": "Indication",
      "name": "alcohol drinking",
      "attributes": {
        "context": "animal models of alcohol drinking"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_136",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Acute administration of rolipram"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_137",
      "type": "PharmEffect",
      "name": "reduces operant self-administration of alcohol",
      "attributes": {
        "context": "dose-dependently reduces operant self-administration of alcohol"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_138",
      "type": "PharmEffect",
      "name": "decreases 2-bottle choice alcohol consumption and preference",
      "attributes": {
        "context": "chronic rolipram treatment decreases 2-bottle choice alcohol consumption and preference"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ]
    },
    {
      "id": "ent_139",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "The non-selective phosphodiesterase inhibitor ibudilast"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_140",
      "type": "PharmEffect",
      "name": "reduces 2-bottle choice alcohol drinking",
      "attributes": {
        "context": "ibudilast reduces 2-bottle choice alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_141",
      "type": "PharmEffect",
      "name": "reduces relapse",
      "attributes": {
        "context": "alcohol drinking and relapse"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_142",
      "type": "Indication",
      "name": "alcohol-preferring",
      "attributes": {
        "context": "alcohol-preferring P rats"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_143",
      "type": "Indication",
      "name": "alcohol-dependent",
      "attributes": {
        "context": "in alcohol-dependent C57BL/6J mice"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_144",
      "type": "PharmEffect",
      "name": "had no effect on alcohol drinking",
      "attributes": {
        "context": "doses which had no effect on alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_145",
      "type": "Compound",
      "name": "PDE inhibitors",
      "attributes": {
        "context": "PDE inhibitors reduce alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_146",
      "type": "PharmEffect",
      "name": "reduce alcohol drinking",
      "attributes": {
        "context": "PDE inhibitors reduce alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_147",
      "type": "Indication",
      "name": "dependence",
      "attributes": {
        "context": "models of genetic susceptibility and dependence"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_148",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {
        "context": "ibudilast is a non-selective PDE inhibitor"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_149",
      "type": "Compound",
      "name": "PDE inhibitor",
      "attributes": {
        "context": "non-selective PDE inhibitor"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_150",
      "type": "Compound",
      "name": "inhibitors to other PDE subtypes",
      "attributes": {
        "context": "inhibitors to other PDE subtypes reduce alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_151",
      "type": "PharmEffect",
      "name": "reduce alcohol drinking",
      "attributes": {
        "context": "PDE subtypes reduce alcohol drinking"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_152",
      "type": "Indication",
      "name": "dependence",
      "attributes": {
        "context": "alcohol drinking and dependence"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_153",
      "type": "Compound",
      "name": "PDE inhibitors",
      "attributes": {
        "context": "effects of nine PDE inhibitors"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_154",
      "type": "Compound",
      "name": "selective PDE4 inhibitors",
      "attributes": {
        "context": "only the selective PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_155",
      "type": "PharmEffect",
      "name": "reduce ethanol intake",
      "attributes": {
        "context": "PDE4 inhibitors reduce ethanol intake"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_156",
      "type": "PharmEffect",
      "name": "reduce preference",
      "attributes": {
        "context": "ethanol intake and preference"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_157",
      "type": "Compound",
      "name": "TP-10",
      "attributes": {
        "context": "the PDE10A inhibitor TP-10"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_158",
      "type": "PharmEffect",
      "name": "reduces alcohol self-administration",
      "attributes": {
        "context": "TP-10 reduces alcohol self-administration"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_159",
      "type": "Compound",
      "name": "TP-10",
      "attributes": {
        "context": "TP-10 also reduces alcohol self-administration"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_160",
      "type": "Indication",
      "name": "alcohol-preferring",
      "attributes": {
        "context": "genetically alcohol-preferring rats"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_161",
      "type": "Indication",
      "name": "alcohol-non-dependent",
      "attributes": {
        "context": "alcohol-non-dependent and -dependent rats"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_162",
      "type": "Indication",
      "name": "alcohol-dependent",
      "attributes": {
        "context": "alcohol-non-dependent and -dependent rats"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_163",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4 and PDE10A are potential therapeutic targets"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_164",
      "type": "Compound",
      "name": "PDE10A",
      "attributes": {
        "context": "PDE4 and PDE10A are potential therapeutic targets"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_165",
      "type": "Indication",
      "name": "alcohol dependence",
      "attributes": {
        "context": "pharmacotherapy of alcohol dependence"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ]
    },
    {
      "id": "ent_166",
      "type": "Compound",
      "name": "Opioids",
      "attributes": {
        "context": "Opioids: PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_167",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 inhibitors reduce morphine-induced"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_168",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "morphine-induced hyperlocomotor activity"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_169",
      "type": "PharmEffect",
      "name": "hyperlocomotor activity",
      "attributes": {
        "context": "morphine-induced hyperlocomotor activity"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_170",
      "type": "PharmEffect",
      "name": "CPP",
      "attributes": {
        "context": "activity and CPP"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_171",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "injections of rolipram suppresses"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_172",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "morphine-induced hyperlocomotion"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_173",
      "type": "PharmEffect",
      "name": "hyperlocomotion",
      "attributes": {
        "context": "morphine-induced hyperlocomotion"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_174",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "administration of rolipram 30 min"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_175",
      "type": "Concentration",
      "name": "30 min",
      "attributes": {
        "context": "rolipram 30 min prior"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_176",
      "type": "PharmEffect",
      "name": "blocks the acquisition of CPP",
      "attributes": {
        "context": "blocks the acquisition of CPP to morphine"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_177",
      "type": "PharmEffect",
      "name": "CPP",
      "attributes": {
        "context": "acquisition of CPP to morphine"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_178",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "CPP to morphine"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_179",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "administration of rolipram 30 min"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_180",
      "type": "Concentration",
      "name": "30 min",
      "attributes": {
        "context": "rolipram 30 min prior"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_181",
      "type": "PharmEffect",
      "name": "CPP",
      "attributes": {
        "context": "expression of morphine CPP"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_182",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "expression of morphine CPP"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_183",
      "type": "Compound",
      "name": "PDE inhibitor",
      "attributes": {
        "context": "The PDE inhibitor rolipram"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_184",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "PDE inhibitor rolipram also inhibits"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_185",
      "type": "PharmEffect",
      "name": "discriminative-stimulus effects",
      "attributes": {
        "context": "inhibits the discriminative-stimulus effects of morphine"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_186",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "effects of morphine in rats"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_187",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "the cAMP signaling cascade"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_188",
      "type": "PharmEffect",
      "name": "conditioned morphine reward",
      "attributes": {
        "context": "acquisition of conditioned morphine reward"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_189",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "conditioned morphine reward"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ]
    },
    {
      "id": "ent_190",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "The PDE4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_191",
      "type": "PharmEffect",
      "name": "does not significantly inhibit heroin self-administration",
      "attributes": {
        "context": "rolipram does not significantly inhibit heroin self-administration"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_192",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "inhibit heroin self-administration"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_193",
      "type": "PharmEffect",
      "name": "dose-dependently decreases the reward values",
      "attributes": {
        "context": "but dose-dependently decreases the reward values"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_194",
      "type": "PharmEffect",
      "name": "decreases the cue- and heroin priming-induced reinstatement of heroin seeking",
      "attributes": {
        "context": "rolipram also decreases the cue- and heroin priming-induced reinstatement of heroin seeking"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_195",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "heroin priming-induced reinstatement"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_196",
      "type": "Indication",
      "name": "heroin seeking",
      "attributes": {
        "context": "reinstatement of heroin seeking"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_197",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Rolipram increases the expression"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_198",
      "type": "PharmEffect",
      "name": "increases the expression of phosphorylated CREB",
      "attributes": {
        "context": "Rolipram increases the expression of phosphorylated CREB"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_199",
      "type": "Compound",
      "name": "phosphorylated CREB",
      "attributes": {
        "context": "expression of phosphorylated CREB"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_200",
      "type": "Indication",
      "name": "heroin-seeking behavior",
      "attributes": {
        "context": "effect on heroin-seeking behavior"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_201",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "that PDE4 inhibitors may be"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_202",
      "type": "PharmEffect",
      "name": "treatment of heroin and morphine dependence",
      "attributes": {
        "context": "for the treatment of heroin and morphine dependence"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_203",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "treatment of heroin and morphine dependence"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_204",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "heroin and morphine dependence"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_205",
      "type": "Indication",
      "name": "heroin and morphine dependence",
      "attributes": {
        "context": "treatment of heroin and morphine dependence"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ]
    },
    {
      "id": "ent_206",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 inhibitors were shown to attenuate"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_207",
      "type": "Compound",
      "name": "naloxone",
      "attributes": {
        "context": "attenuate naloxone-precipitated morphine withdrawal symptoms"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_208",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "naloxone-precipitated morphine withdrawal symptoms"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_209",
      "type": "PharmEffect",
      "name": "attenuate",
      "attributes": {
        "context": "attenuate naloxone-precipitated morphine withdrawal symptoms"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_210",
      "type": "Indication",
      "name": "morphine withdrawal symptoms",
      "attributes": {
        "context": "naloxone-precipitated morphine withdrawal symptoms"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_211",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "increase in PDE4 activity"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_212",
      "type": "Compound",
      "name": "cyclic AMP",
      "attributes": {
        "context": "cyclic AMP was significantly increased"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_213",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "levels of cAMP, which may be involved"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_214",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "PDE4 inhibitors rolipram dampen naloxone-precipitated"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_215",
      "type": "PharmEffect",
      "name": "dampen",
      "attributes": {
        "context": "rolipram dampen naloxone-precipitated behavioral signs"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_216",
      "type": "Indication",
      "name": "morphine withdrawal",
      "attributes": {
        "context": "behavioral signs of morphine withdrawal"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_217",
      "type": "Indication",
      "name": "teeth-chattering",
      "attributes": {
        "context": "such as teeth-chattering"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_218",
      "type": "Indication",
      "name": "tremor",
      "attributes": {
        "context": "tremor"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_219",
      "type": "Indication",
      "name": "piloerection",
      "attributes": {
        "context": "piloerection"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_220",
      "type": "Indication",
      "name": "lacrimation",
      "attributes": {
        "context": "lacrimation"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_221",
      "type": "Indication",
      "name": "rhinorrhea",
      "attributes": {
        "context": "rhinorrhea"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_222",
      "type": "Indication",
      "name": "ptosis",
      "attributes": {
        "context": "ptosis"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_223",
      "type": "Indication",
      "name": "spontaneous jumping",
      "attributes": {
        "context": "spontaneous jumping"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_224",
      "type": "Indication",
      "name": "wet-dog shakes",
      "attributes": {
        "context": "wet-dog shakes"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_225",
      "type": "Indication",
      "name": "weight loss",
      "attributes": {
        "context": "weight loss"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_226",
      "type": "Indication",
      "name": "withdrawal syndrome",
      "attributes": {
        "context": "attenuation of withdrawal syndrome"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_227",
      "type": "Compound",
      "name": "c-Fos protein",
      "attributes": {
        "context": "expression of c-Fos protein induced by naloxone"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_228",
      "type": "PharmEffect",
      "name": "blocked",
      "attributes": {
        "context": "blocked the increase in the expression"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ]
    },
    {
      "id": "ent_229",
      "type": "Indication",
      "name": "drug addiction",
      "attributes": {
        "context": "pharmacological intervention of drug addiction"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_230",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "a number of PDE4 inhibitors have been approved"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_231",
      "type": "Indication",
      "name": "COPD",
      "attributes": {
        "context": "treatment of COPD"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_232",
      "type": "Indication",
      "name": "inflammatory diseases",
      "attributes": {
        "context": "treatment of COPD and inflammatory diseases"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_233",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "repurpose these PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_234",
      "type": "Indication",
      "name": "drug addiction",
      "attributes": {
        "context": "treatment of drug addiction"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ]
    },
    {
      "id": "ent_235",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 inhibitors such as rolipram"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_236",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "such as rolipram often cause nausea"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_237",
      "type": "PharmEffect",
      "name": "nausea",
      "attributes": {
        "context": "often cause nausea and emesis"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_238",
      "type": "PharmEffect",
      "name": "emesis",
      "attributes": {
        "context": "nausea and emesis, which prevent their clinical utility"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_239",
      "type": "PharmEffect",
      "name": "emetic effects",
      "attributes": {
        "context": "The emetic effects are likely mediated"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_240",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "mediated by PDE4 expressed in the area postrema"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_241",
      "type": "Compound",
      "name": "PDE4A",
      "attributes": {
        "context": "PDE4A is predominantly expressed"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_242",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "PDE4B is highly expressed"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ]
    },
    {
      "id": "ent_243",
      "type": "PharmEffect",
      "name": "vomit",
      "attributes": {
        "context": "Why can't rodents vomit?"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_244",
      "type": "Compound",
      "name": "Cannabinoid",
      "attributes": {
        "context": "Cannabinoid receptor signaling."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_245",
      "type": "Compound",
      "name": "phosphodiesterase-4",
      "attributes": {
        "context": "Inhibition of phosphodiesterase-4 decreases ethanol intake"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_246",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "decreases ethanol intake in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_247",
      "type": "PharmEffect",
      "name": "decreases ethanol intake",
      "attributes": {
        "context": "Inhibition of phosphodiesterase-4 decreases ethanol intake in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_248",
      "type": "PharmEffect",
      "name": "drug reward",
      "attributes": {
        "context": "Neurocircuitry of drug reward."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_249",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "modulate cocaine-induced place preference in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_250",
      "type": "PharmEffect",
      "name": "cocaine-induced place preference",
      "attributes": {
        "context": "modulate cocaine-induced place preference in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_251",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {
        "context": "Prevention of methamphetamine-induced behavioral sensitization"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_252",
      "type": "PharmEffect",
      "name": "behavioral sensitization",
      "attributes": {
        "context": "methamphetamine-induced behavioral sensitization in rats"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_253",
      "type": "Compound",
      "name": "cyclic AMP phosphodiesterase inhibitor",
      "attributes": {
        "context": "by a cyclic AMP phosphodiesterase inhibitor, rolipram."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_254",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "by a cyclic AMP phosphodiesterase inhibitor, rolipram."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_255",
      "type": "Compound",
      "name": "type IV phosphodiesterases",
      "attributes": {
        "context": "The involvement of type IV phosphodiesterases in cocaine-induced sensitization"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_256",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "in cocaine-induced sensitization and subsequent pERK expression"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_257",
      "type": "PharmEffect",
      "name": "cocaine-induced sensitization",
      "attributes": {
        "context": "in cocaine-induced sensitization and subsequent pERK expression"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_258",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase",
      "attributes": {
        "context": "Comparison of cAMP-specific phosphodiesterase mRNAs distribution"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_259",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "Learning mechanisms in addiction: synaptic plasticity"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_260",
      "type": "Compound",
      "name": "drugs of abuse",
      "attributes": {
        "context": "exposure to drugs of abuse."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_261",
      "type": "Compound",
      "name": "cyclic AMP-specific phosphodiesterase 4",
      "attributes": {
        "context": "Lack of cyclic AMP-specific phosphodiesterase 4 activation"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_262",
      "type": "Compound",
      "name": "naloxone",
      "attributes": {
        "context": "during naloxone-precipitated morphine withdrawal in rats."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_263",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "naloxone-precipitated morphine withdrawal in rats."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_264",
      "type": "PharmEffect",
      "name": "morphine withdrawal",
      "attributes": {
        "context": "naloxone-precipitated morphine withdrawal in rats."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_265",
      "type": "Compound",
      "name": "phosphodiesterase 4",
      "attributes": {
        "context": "Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_266",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "reverses morphine-induced ventilatory disturbance without loss of analgesia."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_267",
      "type": "PharmEffect",
      "name": "morphine-induced ventilatory disturbance",
      "attributes": {
        "context": "reverses morphine-induced ventilatory disturbance without loss of analgesia."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_268",
      "type": "PharmEffect",
      "name": "analgesia",
      "attributes": {
        "context": "without loss of analgesia."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_269",
      "type": "Compound",
      "name": "type IV phosphodiesterase inhibitors",
      "attributes": {
        "context": "The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram,"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_270",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {
        "context": "The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram,"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_271",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Ro 20-1724 and rolipram, block the initiation of cocaine self-administration."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_272",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "block the initiation of cocaine self-administration."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_273",
      "type": "PharmEffect",
      "name": "cocaine self-administration",
      "attributes": {
        "context": "block the initiation of cocaine self-administration."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_274",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase inhibitor",
      "attributes": {
        "context": "of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_275",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_276",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "rolipram and cocaine on brain stimulation reward."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_277",
      "type": "PharmEffect",
      "name": "brain stimulation reward",
      "attributes": {
        "context": "cocaine on brain stimulation reward."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_278",
      "type": "Compound",
      "name": "Phosphodiesterase 4",
      "attributes": {
        "context": "Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_279",
      "type": "Compound",
      "name": "dopamine D1 receptor",
      "attributes": {
        "context": "enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_280",
      "type": "Compound",
      "name": "phosphodiesterase-4 inhibitor",
      "attributes": {
        "context": "The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_281",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_282",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "heroin-seeking behavior induced by cues or heroin priming in rats."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_283",
      "type": "PharmEffect",
      "name": "heroin-seeking behavior",
      "attributes": {
        "context": "rolipram attenuates heroin-seeking behavior induced by cues or heroin priming"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_284",
      "type": "Compound",
      "name": "phosphodiesterase",
      "attributes": {
        "context": "comparison of phosphodiesterase mRNA distribution in human brain"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_285",
      "type": "Compound",
      "name": "phosphodiesterase-4",
      "attributes": {
        "context": "Localization of phosphodiesterase-4 isoforms in the medulla"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_286",
      "type": "Compound",
      "name": "phosphodiesterase inhibitors",
      "attributes": {
        "context": "The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference"
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_287",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "extinction of cocaine-induced conditioned place preference in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    },
    {
      "id": "ent_288",
      "type": "PharmEffect",
      "name": "cocaine-induced conditioned place preference",
      "attributes": {
        "context": "extinction of cocaine-induced conditioned place preference in mice."
      },
      "source_chunk_ids": [
        "18d0a3ebb78da87a3fd540300a17dbe6"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:03.976611+00:00",
    "original_file": "entities.json"
  }
}